- Home
- CTSO vs MOB Comparison
CTSO vs MOB Comparison
Compare CTSO & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTSO | MOB |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7M | 75.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CTSO | MOB |
|---|---|---|
| Price | $0.73 | $7.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.38 | ★ $10.00 |
| AVG Volume (30 Days) | 123.7K | ★ 327.2K |
| Earning Date | 11-13-2025 | 08-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,979,520.00 | $2,826,361.00 |
| Revenue This Year | $11.93 | $142.38 |
| Revenue Next Year | $21.22 | $99.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.89 | N/A |
| 52 Week Low | $0.60 | $1.31 |
| 52 Week High | $1.61 | $11.02 |
Technical Indicators
Market Signals| Indicator | CTSO | MOB |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 55.24 |
| Support Level | $0.75 | $5.88 |
| Resistance Level | $0.85 | $7.56 |
| Average True Range (ATR) | 0.08 | 0.89 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 55.60 | 78.49 |
Price Performance
Historical ComparisonAbout CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.